Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MicroPhage Inc.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
Noteworthy news from medtech start-ups, including MicroPhage's bacteriophage technology to identify drug-resistant bacteria, Healionics' technology for enhancing device biocompatability, and Gel Delivery Solutions' novel thermo-reversible drug delivery gel.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.